TPP-C8-CO-DSG bromide
TPP-C8-CO-DSG bromide is a derivative of Diosgenin (HY-N0177) and an anticancer agent. TPP-C8-CO-DSG bromide downregulates Bcl-2 expression and upregulates Bax expression. TPP-C8-CO-DSG bromide promotes the cleavage of Caspase 9, Caspase 3 and PARP-1. TPP-C8-CO-DSG bromide depolarizes mitochondrial membrane potential, reduces intracellular ATP production, and induces intracellular ROS accumulation. TPP-C8-CO-DSG bromide promotes Apoptosis. TPP-C8-CO-DSG bromide exhibits anticancer activity against prostate cancer, breast cancer, lung adenocarcinoma, cervical cancer and colorectal cancer. TPP-C8-CO-DSG bromide can be used in the research of cervical cancer.
For research use only. We do not sell to patients.
- Formula: C54H72BrO4P
- Molecular Weight:896.02
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Caspase Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
Bcl-2 |
Bax |
Caspase 9 |
Caspase 3 |
PARP-1 |
In Vitro
TPP-C8-CO-DSG (bromide) (48 h) potently inhibits proliferation of PC-3, A549, MCF-7, HeLa, and HCT116 cancer cells with IC50 values ranging from 0.10 to 3.1 μM, and exhibits selective toxicity with an IC50 of 39.0 μM in normal L02 cells[1].
TPP-C8-CO-DSG (bromide) (0.02-0.5 μM; 36 h) dose-dependently depolarizes the mitochondrial membrane potential in HeLa cells, with significant reductions observed at concentrations as low as 0.02 μM after 36 h of treatment[1].
TPP-C8-CO-DSG (bromide) (0.02-0.5 μM; 36 h) dose-dependently reduces intracellular ATP production in HeLa cells, causing an 80.1% reduction at the highest tested concentration of 0.5 μM after 36 h of treatment[1].
TPP-C8-CO-DSG (bromide) (0.02-0.5 μM; 24 h) dose-dependently induces intracellular ROS accumulation in HeLa cells, with a 28.1-fold increase observed at 0.5 μM after 24 h of treatment[1].
TPP-C8-CO-DSG (bromide) (0.02-0.5 μM; 36 h) dose-dependently promotes apoptosis and necrosis in HeLa cells, with marked morphological changes observed at concentrations of 0.1 μM and 0.5 μM after 36 h of treatment[1].
TPP-C8-CO-DSG (bromide) (0.02-0.5 μM; 36 h) dose-dependently induces early and late apoptosis in HeLa cells, with a combined apoptotic rate of 48.04% observed at 0.5 μM after 36 h of treatment[1].
TPP-C8-CO-DSG (bromide) (0.02-0.5 μM; 36 h) induces apoptosis in HeLa cells via a mitochondria-associated pathway, characterized by upregulation of pro-apoptotic proteins, downregulation of anti-apoptotic Bcl-2, and activation of the caspase cascade after 36 h of treatment[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HeLa
-
Concentration:0.02-0.5 μM
-
Incubation Time:36 h
-
Result:Showed faint red and blue fluorescence in cells treated with 0.02 μM, while cells treated with 0.1 μM and 0.5 μM showed increased intensity of bright red and blue fluorescence, indicating a dose-dependent increase in apoptosis and necrosis.\nCaused a concentration-dependent increase in early and late apoptotic cell populations.
Increased early apoptotic cells from 6.25% (control) to 30.02% (0.5 μM), while late apoptotic cells increased from 2.31% (control) to 18.02% (0.5 μM).
Made the early and late apoptosis rates 18.0- and 45.1-fold higher than the control, respectively.
-
Cell Line:HeLa
-
Concentration:0.02-0.5 μM
-
Incubation Time:36 h
-
Result:Upregulated expression of pro-apoptotic proteins Bax, cytochrome c, cleaved caspase 9, cleaved caspase 3, and cleaved PARP-1.
Downregulated expression of anti-apoptotic protein Bcl-2.
Increased the ratios of cleaved caspase 9 to caspase 9, cleaved caspase 3 to caspase 3, and cleaved PARP-1 to PARP-1.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:AB strain (larval stage, 48 h post-fertilization)[1]
-
Dosage:1.6 μg/mL
-
Administration:48-hour treatment
-
Result:Significantly reduced the fluorescence intensity of HeLa tumor xenografts in zebrafish, indicating inhibition of HeLa cell proliferation.
Chemical Information
-
Molecular Weight 896.02
-
Formula C54H72BrO4P
-
SMILES
O=C(CCCCCCCC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)O[C@@]4(CC5=CC[C@@]6([C@@]([H])([C@]5(CC4)C)CC[C@]7([C@]6(C[C@]8([C@@]7([C@@]([H])([C@]9(O8)CC[C@@](C)(CO9)[H])C)[H])[H])[H])C)[H])[H].[Br-]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Mitochondrial membrane-potential fluorescent assay
Mitochondrial membrane potential fluorescent assays estimate ΔΨm in living cells using lipophilic cationic dyes such as TMRM, TMRE, rhodamine 123, and JC-1, which accumulate in mitochondria according to membrane polarization; loss of signal after FCCP or CCCP treatment is interpreted as mitochondrial depolarization. TMRM/TMRE and rhodamine 123 are commonly used for semi-quantitative live-cell microscopy or flow cytometry, while JC-1 can report a shift from red aggregate fluorescence to green monomer fluorescence during depolarization; interpretation requires controls because dye concentration, quenching mode, cell type, dye efflux, and mitochondrial mass can affect fluorescence independently of ΔΨm.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Fluorescent plasma-membrane potential dye assay
Fluorescent plasma-membrane potential dye assays measure changes in cell membrane potential using voltage-sensitive dyes whose fluorescence changes when cells depolarize or hyperpolarize. Anionic bis-oxonol dyes such as DiBAC4(3) enter depolarized cells more readily and show increased fluorescence after intracellular binding, while hyperpolarization reduces dye accumulation and fluorescence. FMP/FLIPR membrane-potential dyes are used for faster, homogeneous microplate assays of ion-channel or receptor-mediated membrane-potential changes.
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)